Keith first saw the impact the MMRF has on patients and their families while spectating at Ironman Lake Placid in 2015.He helped his son fundraise in following years, and then regained his love of cycling while following the R2V Cross Country Riders. He began to train and joined them on the final leg of their ride.This year, Keith looks to take on a bigger challenge and increase his impact as a member of the team riding from Vermont to Canada.”I’m looking forward to a once in a lifetime ride, while helping an amazing charity”
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More